To cite this paper use one of the standards below:
In vitro digestion systems have been widely used as tools to evaluate the release and bioavailability of bioactive compounds in the gastrointestinal tract, offering significant advantages over in vivo models, such as lower cost, greater reproducibility, and the absence of ethical concerns. Aiming to standardize these assays, the INFOGEST 2.0 protocol was developed, which sequentially simulates the oral, gastric, and intestinal phases of human digestion. Therefore, the objective of this study is to investigate the release of vitamin E from microcapsules produced by complex coacervation, using lentil protein isolate and lactoferrin as wall materials. For this research, lentils were purchased from the local market in Volta Redonda, lactoferrin was acquired from FrieslandCampina (Amersfoort, Netherlands), and vitamin E from Sigma (USA). The water used was ultrapure, with a conductivity of 0.05 μS/cm (Master System P&D, Gehaka, Brazil), and all other reagents were of analytical grade. The equipment used included: an analytical balance (AY220, Shimadzu, Brazil), a pH meter (mPA210, Tecnopon, Brazil), a shaker (TE-424, Tecnal, Brazil), and a Biomate 3S spectrophotometer (Thermo Fisher Scientific, USA). Simulated fluids for saliva (SSF), gastric juice (SGF), and intestinal fluid (SIF) were prepared, and digestion was conducted sequentially in the oral (2 min), gastric (2 h, pH 3.0), and intestinal (2 h, pH 7.0) phases at 37 °C, with the addition of the corresponding reagents and enzymes in the quantities recommended by the INFOGEST 2.0 protocol. Throughout the process, 0.2 mL aliquots were collected at 2, 5, 30, 60, 90, 120, 150, 180, 210, and 240 minutes, then diluted in ethanol and analyzed using a spectrophotometer at a wavelength of 290 nm. During the simulated digestion, a decreasing release of vitamin E was observed, with higher release in the gastric phase (58.6%–52.3%) and lower in the intestinal phase (42%–36.7%), indicating early release in the stomach. Given the low final bioaccessibility (35.5%), the results highlight the need to incorporate a crosslinking agent into the microcapsule formulation to improve gastric resistance and enhance intestinal release, which is the site of vitamin absorption. Therefore, gastrointestinal simulation is an essential tool in the development and validation of functional foods, as well as for optimizing encapsulation formulations and technologies.
Views per month
Galoá count, excluding known robots. Updated on 30/09/2026.
Views per month
Galoá count, excluding known robots. Updated on 30/09/2026.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper